Loading...
*  Influenza | NIH: National Institute of Allergy and Infectious Diseases
Most people who get the flu get better within two weeks, but some people may develop serious complications, such as pneumonia. ...
  https://www.niaid.nih.gov/diseases-conditions/influenza
*  Systemic Steroid Treatment for Severe Expanding Pneumococcal Pneumonia
... Eran Lavi,1 David Shoseyov,1 Natalia Simanovsky,2 and ... Figure 1: A 5-year-old patient with severe expanding pneumococcal pneumonia. (a) Note "white hemithorax" on the left with ... We present a case of a child with severe expanding pneumococcal pneumonia that responded to systemic steroids. ... due to a rapidly expanding pneumococcal pneumonia. The administration of systemic steroids resulted in a dramatic response with ...
  https://www.hindawi.com/journals/cripe/2015/186302/
*  Pneumococcal vaccine reduced pneumococcal pneumonia and associated mortality
The study showed that 23-valent pneumococcal vaccine reduced pneumococcal pneumonia in nursing home residents and reduced death ... Background:There is limited knowledge of serotypes that cause non-bacteremic pneumococcal pneumonia (NBP). Here we report ... Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for ... Controversy persists over the benefits of pneumococcal polysaccharide vaccine (PPV) for adults at high risk for pneumococcal ...
  http://connection.ebscohost.com/c/articles/51696560/pneumococcal-vaccine-reduced-pneumococcal-pneumonia-associated-mortality
*  Severe complicated pneumococcal pneumonia in young adults | European Respiratory Society
Severe complicated pneumococcal pneumonia in young adults. Sebastien Ellis, Matthew Harris, Suzanne Shuttleworth, Chris Taylor ... Severe complicated pneumococcal pneumonia in young adults. Sebastien Ellis, Matthew Harris, Suzanne Shuttleworth, Chris Taylor ... Severe complicated pneumococcal pneumonia in young adults. Sebastien Ellis, Matthew Harris, Suzanne Shuttleworth, Chris Taylor ... and disease severity in adults admitted with pneumococcal pneumonia.. Methods: A cohort of 21 inpatients with pneumococcal ...
  http://erj.ersjournals.com/content/38/Suppl_55/p2483
*  NIOSHTIC-2 Publications Search - 20035942 - Risk-factors for adverse outcome in persons with pneumococcal pneumonia.
Retrospective chart review of persons with pneumococcal bacteremia and pneumonia. Setting: Tertiary care medical center ( ... To identify risk factors for death and respiratory failure in persons with penicillin-sensitive pneumococcal bacteremia and ... pneumonia from data available at initial clinical evaluation, Design: ... One hundred two consecutive adults admitted to the hospital for treatment of pneumococcal pneumonia with bacteremia Results: Of ...
  https://www.cdc.gov/niosh/nioshtic-2/20035942.html
*  Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia - Tabular View - ClinicalTrials.gov
Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia. The safety and scientific validity of this study ... Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia. Official Title ICMJE Comparison Between ... and patients with a documented pneumococcal pneumonia in the previous 4 weeks ... this study is to compare levofloxacin vs ceftriaxone impact on the cytokine production in patients with pneumococcal pneumonia. ...
  https://clinicaltrials.gov/ct2/show/record/NCT00429975
*  Modular Transcriptional Networks of the Host Pulmonary Response during Early and Late Pneumococcal Pneumonia | SpringerLink
... remains the most lethal bacterial pathogen and the dominant agent of community-acquired pneumonia. Treatment has perennially ... Differential Host Gene Expression during Pneumococcal Pneumonia. To confirm induction of pneumonia after infection with Spneu ... 2009) Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 374:1543-1556.CrossRefGoogle Scholar ... In this study a mouse model of early and late acute pneumococcal pneumonia was employed to construct a scale-free modular ...
  https://link.springer.com/article/10.2119%2Fmolmed.2014.00263
*  Development of a model of focal pneumococcal pneumonia in young rats
... Author: Saladino, Richard A; Malley, Richard; Stack, Anne ... Development of a model of focal pneumococcal pneumonia in young rats. DSpace/Manakin Repository. * DASH Home ... Development of a model of focal pneumococcal pneumonia in young rats. Journal of Immune Based Therapies and Vaccines 2: 2.. ... We propose that this model may be useful for the evaluation of vaccines for the prevention of pneumococcal pneumonia.. ...
  https://dash.harvard.edu/handle/1/4874841
*  Reactive Oxygen Species Regulate Neutrophil Recruitment and Survival in Pneumococcal Pneumonia
For the commonest cause of community-acquired pneumonia, pneumococcal pneumonia, NADPH oxidase activation is not required for ... studied pneumococcal pneumonia in these mice. We demonstrate that NADPH oxidase-dependent ROS are redundant for pneumococcal ... Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice. Infect Immun 2007;75:1586-1597. [PMC free ... Conclusions: During pneumococcal pneumonia, NADPH oxidase-derived reactive oxygen species are redundant for host defense but ...
  http://pubmedcentralcanada.ca/pmcc/articles/PMC2643216/?lang=en-ca
*  Ventilator-induced lung injury in severe pneumococcal pneumonia: Protection by adrenomedullin | European Respiratory Society
Ventilator-induced lung injury in severe pneumococcal pneumonia: Protection by adrenomedullin. Holger Müller-Redetzky, Daniel ... Ventilator-induced lung injury in severe pneumococcal pneumonia: Protection by adrenomedullin. Holger Müller-Redetzky, Daniel ... Ventilator-induced lung injury in severe pneumococcal pneumonia: Protection by adrenomedullin. Holger Müller-Redetzky, Daniel ... Ventilator-induced lung injury in severe pneumococcal pneumonia: Protection by adrenomedullin Message Subject (Your Name) has ...
  http://erj.ersjournals.com/content/40/Suppl_56/4322
*  Pneumococcal pneumonia - Wikipedia
"Pneumococcal Pneumonia". www.niaid.nih.gov. Retrieved 2016-04-26. "Pneumococcal Disease , Facts About Pneumonia , CDC". www.cdc ... Pneumococcal pneumonia is a type of bacterial pneumonia that is specifically caused by Streptococcus pneumoniae. S. pneumoniae ... It is the most common bacterial pneumonia found in adults. The estimated number of Americans with pneumococcal pneumonia is ... The symptoms of pneumococcal pneumonia can occur suddenly, typically presenting as a severe chill, later including a severe ...
  https://en.wikipedia.org/wiki/Pneumococcal_pneumonia
*  Pneumonia, Pneumococcal
Pneumococcal. On-line free medical diagnosis assistant. Ranked list of possible diseases from either several symptoms or a full ... Pneumococcal"Drugs, active principles and "Pneumonia, Pneumococcal"Medicinal plantsQuestions and answers from other usersNews ... Detailed information through a personalized searchRanked list of diseases related to "Pneumonia, ...
  https://lookfordiagnosis.com/mesh_info.php?term=Pneumonia%2C+Pneumococcal&lang=1
*  The problem of early mortality in pneumococcal pneumonia: a study of risk factors | European Respiratory Society
Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60: 759-776. ... The problem of early mortality in pneumococcal pneumonia: a study of risk factors. Joaquín Burgos, Manel Luján, M. Nieves ... Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010; 51: 692-699. ... Current concepts in host-microbe interaction leading to pneumococcal pneumonia. Curr Opin Infect Dis 2013; 26: 277-283. ...
  http://erj.ersjournals.com/content/46/2/561
*  The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia | Gut
Pneumococcal pneumonia: mechanisms of infection and resolution. Chest 2012;142:482-91. doi:10.1378/chest.12-0210. ... Interleukin 1 receptor-associated kinase m impairs host defense during pneumococcal pneumonia. J Infect Dis 2012;205:1849-57. ... Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009;374:1543-56. doi:10.1016/S0140-6736(09)61114-4. ... Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Blood 2003; ...
  https://gut.bmj.com/content/65/4/575
*  What is pneumococcal pneumonia called that for? - Answered by top doctors on HealthTap
How efficient are pneumococcal vaccines for preventing pneumonia in adults?Do they prevent all types of pneumonia more How ... So its nickname became "pneumococcus, " which causes "pneumococcal" pneumonia. Would you like to video or text chat with me? ... Does a pneumococcal vaccine give complete immunity agst pneumonia and does it last life long? Thx ... Can you get pneumonia from a child who just got the prevnar (pneumococcal vaccine) vaccine? ...
  https://www.healthtap.com/user_questions/212201-what-is-pneumococcal-pneumonia-called-that-for
*  The intensive care management, mortality and prognostic indicators in severe community-acquired pneumococcal pneumonia |...
To determine mortality and factors that might predict outcome in severe community-acquired pneumococcal pneumonia treated by a ... Ortqvist A, Kalin M, Julander I, Mufson MA (1993) Deaths in bacteremic pneumococcal pneumonia. Chest 103: 710-716PubMedGoogle ... Marrie TJ (1992) Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect 24: 247-256PubMedGoogle Scholar ... Banks RA, George RC, McNicol MW (1984) Pneumococcal pneumonia with bacteraemia. Respir Med 78: 352-357Google Scholar ...
  https://link.springer.com/article/10.1007%2FBF01709542
*  Table 1 - Macrolide Resistance in Adults with Bacteremic Pneumococcal Pneumonia - Volume 12, Number 8-August 2006 - Emerging...
We conducted a case-control study of adults with bacteremic pneumococcal pneumonia to identify factors associated with ... Macrolide Resistance in Adults with Bacteremic Pneumococcal Pneumonia Joshua P. Metlay*†. , Neil O. Fishman†, Marshall M. Joffe ...
  https://wwwnc.cdc.gov/eid/article/12/8/06-0017-t1
*  Fluoroquinolone and Macrolide Treatment Failure in Pneumococcal Pneumonia and Selection of Multidrug-Resistant Isolates -...
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med. 2002;346:747-50. DOIPubMed ... We describe failure of treatment of pneumococcal pneumonia in a 71-year-old man, who was allergic to penicillin and had a ... Fluoroquinolone and Macrolide Treatment Failure in Pneumococcal Pneumonia and Selection of Multidrug-Resistant Isolates On This ... Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. ...
  https://wwwnc.cdc.gov/eid/article/9/9/02-0810_article
*  Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia
... Daisuke Yoshioka,a,b ... Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect Immun 65:257-260. [PMC free ... Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this ... In the present study, a lethal mouse model of pneumococcal pneumonia, which was likely complicated with bacteremia (19) and ...
  http://pubmedcentralcanada.ca/pmcc/articles/PMC5038280/
*  Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia. - Semantic Scholar
In this neutropenic pneumonia model, CLR was less efficacious against S. pneumoniae strains for which MICs were ,or=4 microg/ml ... was evaluated with a murine model of pneumonia. Eight Streptococcus pneumoniae isolates, including three macrolide-sensitive ... A strain-independent method to induce progressive and lethal pneumococcal pneumonia in neutropenic mice. *Andrés Felipe Zuluaga ... Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia.. @article{ ...
  https://www.semanticscholar.org/paper/Pharmacodynamic-assessment-of-clarithromycin-in-a-Tessier-Kim/811bd783f0a512f599eb55f39ee7232ccae1a873
*  Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era | Lurie...
Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era. Olarte, L ... Research InnovationPublications Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal ... Background.: The impact of PCV13 on a number of clinical aspects of pneumococcal pneumonia (PP) in children has not been ... Annual pneumococcal pneumonia hospitalization rates per 100 000 admissions with 95% confidence intervals were calculated. ...
  https://www.luriechildrens.org/en/research/publications/pneumococcal-pneumonia-requiring-hospitalization-in-us-children-in-the-13-valent-pneumococcal-conjugate-vaccine-era/
*  Pneumococcal Pneumonia - Health - Lifestyle
The main and very important symptom of pneumococcal pneumonia is homogenous consolidation of one or more lobes or segments of ... Pneumonia - Symptoms,Signs and Treatment. Inflammation of the lungs due to infection is called pneumonia. Pneumonia is caused ... Pneumococcal Pneumonia. July 16, 2012 by: Dr. Simran Kaur Points: 8 Category: Health Earning $0.25 Views: 542 The main and very ... Pneumococcal pneumonia is divided into four stages -. i) Stage of congestion.. ii) Stage of red hepatisation.. iii) Stage of ...
  http://www.exposeknowledge.com/kb/8564-pneumococcal-pneumonia.aspx
*  PREVNAR® 13 NOW APPROVED IN CANADA FOR THE PREVENTION OF VACCINE-TYPE PNEUMOCOCCAL PNEUMONIA IN ADULTS 18 YEARS OF AGE AND...
... pneumococcal 13-valent conjugate vaccine) has received Health Canada's approval for active immunization of adults 18 years of ... age and older for the prevention of pneumonia caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C ... there are an estimated three cases of non-invasive pneumococcal pneumonia.[6] While non-invasive pneumococcal disease is more ... "Pneumococcal pneumonia is a leading cause of hospitalization and can pose a serious health risk - particularly to older adults ...
  http://www.pfizer.ca/node/1801